In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

invoX Pharma Limited (“invoX”), a research-driven global biopharmaceutical company with an advancing pipeline of innovative products, and Insilico Medicine (“Insilico”), a leading and global clinical ...

WEST LAFAYETTE, Ind., Feb. 11, 2026 /PRNewswire/ -- Improved Pharma, a leader in pharmaceutical research and solid-state chemistry, is pleased to announce a ...

Pharmaceutical companies are often lambasted for rising drug costs. For example, the price of new drugs entering the US market in 2023 was 35% higher than in 2022. According to an analysis from ...

The pandemic led to massive increases in research and development among pharmaceutical companies as they raced to discover vaccines and treatments for Covid-19. But those days are over, and many ...

New Delhi: The government has sought expressions of interest (EoI) for research & development (R&D) projects to develop novel technologies in medicine, including medical devices and drugs for ...

Copenhagen, DK and Boston, MA, U.S. November 05, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of ...

Purdue University and leading academic and research universities in Ireland continue to build upon existing partnerships to bolster additional collaborative research efforts and study abroad ...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announced that it has been selected ...